Use of the wearable cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry)

Circulation

Volumn 132, Issue 17, 2015, Pages 1613-1619

  Kutyifa, Valentina ^a   Moss, Arthur J ^a   Klein, Helmut ^a   Biton, Yitschak ^a   McNitt, Scott ^a   MacKecknie, Bonnie ^a   Zareba, Wojciech ^a   Goldenberg, Ilan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Death, sudden, cardiac; Defibrillator, implantable; Defibrillators; Tachycardia, ventricular

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; BRUGADA SYNDROME; CARDIAC PATIENT; CONGENITAL HEART DISEASE; CONVULSIVE THERAPY; DEFIBRILLATOR; FAINTNESS; FEMALE; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL HISTORY; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; THERAPY DELAY; WEARABLE CARDIOVERTER DEFIBRILLATOR; ADVERSE EFFECTS; AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY; CARDIOVERSION; COMPLICATION; CONGENITAL HEART MALFORMATION; DEATH, SUDDEN, CARDIAC; DEVICES; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PRESCRIPTION; REGISTER; STATISTICS AND NUMERICAL DATA; UTILIZATION;

CARDIOVASCULAR AGENT;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT COMPLIANCE; PRESCRIPTIONS; PROSPECTIVE STUDIES; REGISTRIES; STROKE VOLUME;

EID: 84945951070     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.015677     Document Type: Article

References (13)

1. Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001;12:369-381.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defbrillator Implantation Trial II Investigators. Prophylactic implantation of a defbrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/NEJMoa013474.
3. Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Higgins SL, Klein H, Pfeffer M, Wilber D, Zareba W. Multicenter automatic defbrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10(4 suppl):34-43. doi: 10.1111/j.1542-474X.2005.00073.x.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defbrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
5. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1-e62. doi: 10.1016/j.hrthm.2008.04.014.
6. Auricchio A, Klein H, Geller CJ, Reek S, Heilman MS, Szymkiewicz SJ. Clinical effcacy of the wearable cardioverter-defbrillator in acutely terminating episodes of ventricular fbrillation. Am J Cardiol. 1998;81:1253-1256. doi: http://dx.doi.org/10.1016/S0002-9149(98)00120-9
7. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ; WEARIT investigators and coordinators; BIROAD investigators and coordinators. Use of a wearable defbrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27:4-9. doi: 10.1111/j.1540-8159.2004.00378.x
8. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, Tchou PJ. Aggregate national experience with the wearable car-dioverter-defbrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56:194-203. doi: 10.1016/j.jacc.2010.04.016.
9. Klein HU, Goldenberg I, Moss AJ. Risk stratifcation for implant-able cardioverter defbrillator therapy: the role of the wearable cardioverter-defbrillator. Eur Heart J. 2013;34:2230-2242. doi: 10.1093/eurheartj/eht167.
10. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283. doi: 10.1056/NEJMoa1211107.
11. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defbrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defbrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158. doi: 10.1056/NEJMoa033088.
12. Sheppard R, Mather PJ, Alexis JD, Starling RC, Boehmer JP, Thohan V, Pauly DF, Markham DW, Zucker M, Kip KE, McNamara DM; IMAC Investigators. Implantable cardiac defbrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2. J Card Fail. 2012;18:675-681. doi: 10.1016/j.cardfail.2012.07.004.
13. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ. Wearable cardioverter-def-brillator use in patients perceived to be at high risk early post-myocar-dial infarction. J Am Coll Cardiol. 2013;62:2000-2007. doi: 10.1016/j. jacc.2013.05.086.